Publications by authors named "Michael Hoemann"

Claim this Profile
P
Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.
Dawn M George, Raymond J Huntley, Kevin Cusack, David B Duignan, Michael Hoemann

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and optimization of furano[3,2-d]pyrimidines as selective spleen tyrosine kinase (Syk) inhibitors.
Michael Hoemann, Noel Wilson, Maria Argiriadi, David Banach, Andrew Burchat

Bioorg Med Chem Lett· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat Pancreas.
Andrew J Long, Erik Sampson, Richard W McCarthy, Christopher M Harris, Marc Barnard, Michael Hoemann

Toxicol Pathol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design strategies to address kinetics of drug binding and residence time.
Kevin P Cusack, Ying Wang, Michael Z Hoemann, Jasmina Marjanovic, Roland G Heym

Bioorg Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological properties of novel antistaphylococcal quinoline-indole agents.
Brunello Oliva, Keith Miller, Nico Caggiano, Alexander J O'Neill, Gregory D Cuny, Michael Z Hoemann

Antimicrob Agents Chemother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives.
Michael Z Hoemann, Roger L Xie, Richard F Rossi, Sylvia Meyer, Alban Sidhu

Bioorg Med Chem Lett· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis